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Ordered mixtures consist of adhering fine particles of a hydrophobic drug to the
surface of larger particles of a water soluble carrier substance (1). Carrier particles dis-
solve in the presence of water, whereby adherent particles of the pharmaceutical sub-
stance disperse throughout the liquid. This eliminates the inherent tendency of hydro-
phobic drug particles to collect into not-readily dissolvable and dispersible aggregate.
Literature reveals that various water soluble excipients such as lactose, mannitol, sor-
bitol and sodium chloride have been extensively used in preparation of ordered mix-
tures (1–3).
Gliclazide is 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphe-
nyl)sulfonylurea with molecular mass of 323.41 (PubChem Database; http://pubchem.
ncbi.nlm.nih.gov). Gliclazide is used for the treatment of type II non-insulin dependent
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The poorly water soluble antidiabetic drug gliclazide was
selected to study the effect of excipients on dissolution
rate enhancement. Ordered mixtures of micronized gli-
clazide with lactose, mannitol, sorbitol, maltitol and so-
dium chloride were prepared by manual shaking of glass
vials containing the drug and excipient(s). Different wa-
ter soluble excipients, addition of surfactant and super-
disintegrant, drug concentration and carrier particle size
influenced the dissolution rate of the drug. Dissolution
rate studies of the prepared ordered mixtures revealed an
increase in drug dissolution with all water soluble exci-
pients. The order of dissolution rate improvement for
gliclazide was mannitol > lactose > maltitol > sorbitol >
sodium chloride. Composite granules of the particle size
range 355–710 mm were superior in increasing the drug
dissolution rate from ordered mixtures. Reducing the
carrier particle size decreased the dissolution rate of the
drug as well as the increase in drug concentration. Kine-
tic modeling of drug release data fitted best the Hixson-
-Crowell model, which indicates that all the ordered mix-
ture formulations followed the cube root law fairly well.
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diabetes mellitus. Values for clog P [calculated log P] and log P [logarithm of partition
coefficient between n-octanol and water, i.e. log (coctanol/cwater)], for gliclazide are 1.09
and 1.97, respectively. Clog P classifies the drug as BCS (Biopharmaceutics Classification
System) class IV and log P values as BCS class II (TSRL Inc. BCS Classification System;
http://69.20.123.154/services/bcs/search.cfm). pKa of gliclazide is 6.9 and intrinsic solubili-
ty (log So, expressed as the average log molar concentration ±1 standard deviation) is
–4.07 ± 0.03 (4). The aqueous solubility of gliclazide at 37 °C is 55 mg mL–1 (5). It was of
interest to improve its dissolution rate using the ordered mixing approach. Attempts ha-
ve already been made to increase the solubility and dissolution rate of gliclazide with
anionic and cationic surfactants (5), by preparing solid dispersions (6–8), in situ
micronisation (9, 10), cogrinding (11) and complexation with cyclodextrins (12).
In the present work, water soluble excipients (lactose, mannitol, maltitol, sorbitol
and sodium chloride), superdisintegrant (sodium starch glycolate, SSG) and surfactant
(sodium lauryl sulphate, SLS) have been used to improve the dissolution rate of glicla-
zide in different formulations prepared by ordered mixing.
EXPERIMENTAL
Materials
Gliclazide was obtained as a gift sample from Ranbaxy Ltd., India. Lactose (Lacto-
chem Fine Powder) was received as a gratis sample from Domo Holland, The Nether-
lands. Mannitol (Pearlitol 200 SD), maltitol (Maltisorb P90), sorbitol (Neosorb P60) and
sodium starch glycolate (Glycolys LV) were obtained as gift samples from Roquette, In-
dia. Sodium chloride and sodium lauryl sulphate were procured from the Central Drug
House, New Delhi, India.
Methods
Average particle size and size distribution of the drug. – Particle size and size distribu-
tion of gliclazide were determined by laser light diffraction. The equipment consisted of
a Malvern Mastersizer 2000 (Malvern Instruments Ltd, UK) including a Scirocco 2000
module for dry measurement operating at 3 ´ 105 pascals air pressure for dispersion. It
was established that sufficient dispersion of particles, but no milling, occurs at this level
of air pressure. Evaluation of data was done by the Malvern software version 5.22 using
the Fraunhofer approximation as the evaluation algorithm. Polystyrene latex particles
were used as dispersion medium.
Preparation of composite carrier granules. – Lactose or mannitol or maltitol or sorbitol
or sodium chloride, and/or sodium starch glycolate, and/or SLS were mixed in a blen-
der (200 g working capacity, customized V blender, Shakti Engineering, Ahmedabad, In-
dia) for 30 minutes. Absolute ethanol was added to the powder mixture and the dough
was screened through a sieve of aperture size 1000 mm to obtain composite carrier gran-
ules; this was followed by drying.
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Mixing of composite carrier granules and gliclazide. – An ordered mixture of gliclazide
(Table I) was prepared by placing the micronized drug between two layers of composite
carrier granules in a borosilicate glass vial (10 mL) and shaking it vigorously by hand for
5 min. This method was found to produce consistently good quality ordered mixtures
when observed by photomicrographs and concentration uniformity was assessed by ho-
mogeneity studies. The procedure had the advantage that it caused no size reduction of
the carrier during mixing.
Homogeneity of gliclazide in ordered mixtures. – The accurately weighed ordered mix-
ture (200 mg) was transferred to a volumetric flask (10 mL). The volume was made up to
the mark with methanol and sonicated (Ultrasonicator 6.5L200H, PCI Analytics, India)
for 30 minutes. Liquid samples were then centrifuged. Supernatant aliquot (500 mL) was
then diluted with distilled water to 10 mL and absorbance was measured at lmax 226 nm
(Pharmaspec UV-1700, Shimadzu, Japan). The concentration was read off from the stan-
dard curve.
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5 min 10 min
GLF1 Lactose – – 125-710 5 73.6 ± 1.3 85.4 ± 1.4
GLF2 Lactose SSG – 125-710 5 85.1 ± 0.9 92.5 ± 1.6
GLF3 Lactose – SLS 125-710 5 71.8 ± 1.1 85.3 ± 1.5
GLF4 Lactose SSG SLS 125-710 5 88.3 ± 1.3 96.8 ± 0.9
GLF5 Lactose SSG SLS 355-710 5 82.4 ± 1.1 88.3 ± 1.4
GLF6 Lactose SSG SLS 250-355 5 77.8 ± 1.3 84.9 ± 0.9
GLF7 Lactose SSG SLS 180-250 5 73.5 ± 1.5 80.7 ± 1.1
GLF8 Lactose SSG SLS 150-180 5 72.7 ± 1.5 80.2 ± 1.1
GLF9 Lactose SSG SLS 125-710 1 83.8 ± 1.4 95.5 ± 1.2
GLF10 Lactose SSG SLS 125-710 7 83.6 ± 1.8 94.4 ± 1.4
GLF11 Lactose SSG SLS 125-710 10 61.9 ± 1.0 79.2 ± 1.0
GMF1 Mannitol – – 125-710 5 82.7 ± 1.3 92.4 ± 1.4
GMF2 Mannitol SSG – 125-710 5 87.4 ± 1.0 94.4 ± 1.6
GMF3 Mannitol – SLS 125-710 5 83.6 ± 1.1 94.7 ± 1.5
GMF4 Mannitol SSG SLS 125-710 5 88.8 ± 1.0 96.0 ± 0.8
GMF5 Mannitol SSG SLS 355-710 5 88.1 ± 1.3 94.7 ± 0.9
GMF6 Mannitol SSG SLS 250-355 5 80.5 ± 1.6 88.3 ± 1.3
GMF7 Mannitol SSG SLS 180-250 5 80.3 ± 1.5 89.2 ± 1.0
GMF8 Mannitol SSG SLS 150-180 5 77.5 ± 1.0 87.1 ± 0.8
GMF9 Mannitol SSG SLS 125-710 1 86.5 ± 1.4 91.6 ± 1.3
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GMF10 Mannitol SSG SLS 125-710 7 83.9 ± 2.0 94.6 ± 1.5
GMF11 Mannitol SSG SLS 125-710 10 60.7 ± 1.0 78.3 ± 1.0
GSF1 Sorbitol – – 125-710 5 65.6 ± 1.4 77.5 ± 1.4
GSF2 Sorbitol SSG – 125-710 5 72.6 ± 1.4 83.1 ± 1.2
GSF3 Sorbitol – SLS 125-710 5 69.1 ± 0.9 80.8 ± 1.6
GSF4 Sorbitol SSG SLS 125-710 5 87.4 ± 1.0 94.3 ± 0.8
GSF5 Sorbitol SSG SLS 355-710 5 85.6 ± 1.5 92.8 ± 1.0
GSF6 Sorbitol SSG SLS 250-355 5 77.7 ± 1.4 87.7 ± 1.1
GSF7 Sorbitol SSG SLS 180-250 5 75.6 ± 1.5 84.9 ± 1.0
GSF8 Sorbitol SSG SLS 150-180 5 70.9 ± 1.3 79.9 ± 1.0
GSF9 Sorbitol SSG SLS 125-710 1 88.4 ± 1.4 98.3 ± 1.2
GSF10 Sorbitol SSG SLS 125-710 7 82.9 ± 1.8 94.0 ± 1.4
GSF11 Sorbitol SSG SLS 125-710 10 61.2 ± 1.0 78.8 ± 1.0
GMTF1 Maltitol – – 125-710 5 68.9 ± 1.3 80.8 ± 1.4
GMTF2 Maltitol SSG – 125-710 5 71.5 ± 1.2 85.2 ± 1.4
GMTF3 Maltitol – SLS 125-710 5 73.9 ± 1.1 85.8 ± 1.5
GMTF4 Maltitol SSG SLS 125-710 5 82.6 ± 1.1 92.7 ± 0.8
GMTF5 Maltitol SSG SLS 355-710 5 82.2 ± 1.3 91.4 ± 0.9
GMTF6 Maltitol SSG SLS 250-355 5 75.1 ± 1.6 85.0 ± 1.2
GMTF7 Maltitol SSG SLS 180-250 5 72.6 ± 1.5 83.5 ± 1.0
GMTF8 Maltitol SSG SLS 150-180 5 70.4 ± 0.5 81.9 ± 0.8
GMTF9 Maltitol SSG SLS 125-710 1 85.3 ± 1.4 91.0 ± 1.5
GMTF10 Maltitol SSG SLS 125-710 7 81.3 ± 4.0 92.5 ± 3.2
GMTF11 Maltitol SSG SLS 125-710 10 61.2 ± 1.0 78.5 ± 0.9
GSCF1 NaCl – – 125-710 5 29.9 ± 0.8 45.7 ± 0.8
GSCF2 NaCl SSG – 125-710 5 38.7 ± 2.1 55.0 ± 1.2
GSCF3 NaCl – SLS 125-710 5 32.4 ± 0.6 48.7 ± 0.9
GSCF4 NaCl SSG SLS 125-710 5 43.5 ± 1.5 66.7 ± 1.1
GSCF5 NaCl SSG SLS 355-710 5 42.6 ± 1.3 60.7 ± 0.9
GSCF6 NaCl SSG SLS 250-355 5 38.2 ± 0.9 61.5 ± 0.8
GSCF7 NaCl SSG SLS 180-250 5 23.9 ± 1.2 35.8 ± 0.9
GSCF8 NaCl SSG SLS 150-180 5 21.2 ± 1.5 30.7 ± 1.1
GSCF9 NaCl SSG SLS 125-710 1 48.9 ± 1.4 70.1 ± 1.2
GSCF10 NaCl SSG SLS 125-710 7 38.2 ± 1.8 54.0 ± 1.4
GSCF11 NaCl SSG SLS 125-710 10 30.0 ± 1.0 40.5 ± 1.0
Gliclazide – – – – – 10.9 ± 1.4 12.8 ± 1.6
Gliclazide
suspension
– – – – – 74.4 ± 0.8 76.5 ± 0.9
a DP – cumulative percent drug release at a particular time, SLS – sodium lauryl sulphate, SSG – sodium
starch glycolate
Scanning electron microscopy (SEM). – Scanning electron microscopy was used to de-
termine the surface coverage of carrier particles by gliclazide particles. A perfectly dried
sample of powder or ordered mixture was mounted onto the stubs using double-sided
adhesive tape. The mounted sample was coated with gold palladium alloy (150–200 10–8 m)
using a fine coat ion sputter (Fine coat ion sputter, JFC-1100, Jeol, Japan). The samples
were subsequently analyzed under the scanning electron microscope (JSM 6100, Jeol, Ja-
pan) for external morphology.
Dissolution studies of ordered mixtures. – Dissolution studies of gliclazide from orde-
red mixture and powdered samples were performed using the USP XXIV (13) paddle
method (TDT-08L, Electrolab, India) at a stirring speed of 100 rpm in distilled water. Sam-
ples of ordered mixture (200 mg) were sequentially added to 900 mL of distilled water,
covered and maintained at 37 ± 0.5 °C. Aliquots of 5 mL were withdrawn and each time
replaced with fresh medium. Obtained samples were analyzed for absorbance at 226 nm.
The univariate ANOVA was applied to the dissolution data at each time point using DDSol-
ver (China Pharmaceutical University, Nanjing, China), which is an add-in Microsoft Ex-
cel added in program for modeling and comparison of dissolution profiles, to determine
significant time ´ group interaction between formulations.
Dissolution studies of pure gliclazide and its suspension. – Pure gliclazide (aggregate form)
and its suspension equivalent to the amount contained in ordered mixtures were also
studied for drug release. Gliclazide suspension was prepared in distilled water contain-
ing 0.5 % sodium lauryl sulphate and stirred for 5 minutes using a propeller mixer. All
the dissolution studies were performed in the same manner as given under dissolution
studies of ordered mixtures.
Mathematical modeling of release kinetics. – The in vitro drug release data were fitted to
various release kinetic models (14), viz. zero-order kinetic model Mo – Mt = kot, first-or-
der model ln (Mt/Mo) = k1t, Higuchi model Mt = K t, Hixon-Crowell cube root model
(Wo)1/3 – (Wt)1/3 = k1/3t, where Mo, Mt and M correspond to the drug amount taken at
zero time, dissolved at a particular time (t) and at infinite () time, respectively. The terms
Wo and Wt refer to the mass of the drug taken initially and at time t, respectively. Vari-
ous other terms, viz. ko, k1, k1/3 and K refer to the release kinetic constants obtained from
the linear curves of zero-order, first-order, Higuchi model and Hixson-Crowell cube root
law, respectively.
RESULTS AND DISCUSSION
Drug particle size, homogeneity of ordered mixtures, scanning electron micrographs
Particle size of the drug plays an important role in formulations of poorly soluble
drugs. Gliclazide in micronized form is used for the preparation of various ordered mix-
tures. The surface weighted mean diameter and volume weighted mean diameter of drug
particles were 2.446 and 3.686 mm, respectively. The specific surface area of gliclazide
drug particles was 2.34 m2 g–1. The homogeneity of the prepared ordered mixtures was
estimated as RSD (%) of their assay value, which were less than 3.5 for different formu-
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lations (Table II). Scanning electron photomicrographs of gliclazide ordered mixtures
with composite granules of lactose and mannitol are presented in Fig. 1. It seems rather
difficult to identify drug particles lodged over the surface of composite granules. How-
ever, the presence of crevices and surface irregularities in photomicrographs are consid-
ered to be the potential sites where micronized gliclazide particles were lodged.
Variables affecting gliclazide release from ordered mixtures
Effect of formulation variables. – Gliclazide release from pure drug powder was 10.9
and 12.8 % after 5 and 10 minutes, respectively, while the drug release from suspension
was 74.4 and 76.5 % after 5 and 10 minutes, respectively. All ordered mixture formula-
tions increased the dissolution rate of gliclazide. The least increase in dissolution rate
was observed with NaCl (Table I; GSCF1 to GSCF11). The order of the dissolution rate
enhancement was mannitol > lactose > maltitol > sorbitol > sodium chloride (Table I).
The dissolution rate of gliclazide from ordered mixtures containing sugar and sugars al-
cohols (Table I, GLF1-GLF11, GMF1-GMF11, GSF1-GSF11, GMTF1-GMTF11) was superior
to gliclazide suspension at initial time points, i.e. 5 and 10 minutes.
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Fig. 1. Photomicrographs showing the surface of ordered mixtures of gliclazide with: (a) lactose, (b)
mannitol.
a) b)
Table II. Homogeneity of gliclazide ordered mixtures
Formulation Gliclazide (%)a
GLF4 101.1 ± 3.0
GMF4 100.8 ± 2.0
GMTF4 101.5 ± 3.0
GSF4 100.0 ± 2.1
GSCF4 101.1 ± 2.3
a Mean ± SD, n = 6.
Addition of superdisintegrant SSG in granules (Table I, GLF1, GLF2, GMF1, GMF2,
GSF1, GSF2, GMTF1, GMTF2, GSCF1, GSCF2) further contributed to the increase in gli-
clazide dissolution from ordered mixtures. Maximum increase of 11.5 and 7.0 % after 5
and 10 min, respectively, was oftained in GLF2 compared to the GLF1. The minimum ef-
fect of superdisintegrant addition of only 1.9 % after 10 minutes was observed in GMF2.
Superdisintegrant swells at a rapid rate and thereby disintegrates the granule so that ca-
rrier particles dissolve at a faster rate, which further increases the ability of the compos-
ite granule to release the individual, mutually discrete primary gliclazide particles. Sur-
factants in the range of 0.5–3 % by mass of the ordered mixture have been suggested to
improve the dissolution of hydrophobic drugs (15). In our studies, a very slight increase
of 0–5 % in dissolution rate was observed (Table I, GLF1, GLF3, GMF1 GMF3, GSF1,
GSF3, GMTF1, GMTF3, GSCF1, GSCF3). When both superdisintegrant and surfactant
were added to a composite granule, the synergistic effect of 6–17 % increase of dissolu-
tion rate after 10 minutes was observed (Table I, GLF1, GLF4, GMF1, GMF4, GSF1, GSF4,
GMTF1, GMTF4, GSCF1, GSCF4). The synergistic increase in dissolution (GMF4 vs.
GMF1) was minimum with mannitol, 6.2 and 3.6 % after 5 and 10 min, respectively. This
was due to the very fast drug release with mannitol in the GMF1 formulation.
Effect of carrier particle size. – The coarsest granule fraction (average particle size
532.5 mm) was most effective in improving the dissolution of gliclazide with all the carri-
ers (Table I, GLF6, GMF6, GSF6, GMTF6, GSCF6). The fine particle size of the composite
carrier granule decreased the dissolution rate (Table I) with all the carriers. In sodium
chloride ordered mixtures, the effect of particle size on the dissolution rate was compar-
atively higher (Table I, GSCF5-GSCF8). The fine ordered mixture (150–180 mm, GSCF8)
released about 30.7 % drug while the coarser ordered mixture (355–710 mm, GSCF5) re-
leased 60.7 % drug in 15 minutes, which was a twofold increase. Coarser particles show
a greater tendency to deviate from spherical size and possess cavities, capillaries and
crevices, which increases the chances of adhesion of fine drug particles on the surface.
This effect may affect the homogeneity of the formulation. Polydisperse carrier particles
(125–710 mm, GLF4, GMF4, GSF4, GMTF4, GSCF4), mixtures of all size ranges of parti-
cles, were equally effective as the coarsest size composite particles in improving the dis-
solution rate (Table I). This is presumably due to the effect of fine particles present along
with the coarse carrier particles.
Effect of drug concentration. – The ordered mixture with 1 and 5 % (m/m) gliclazide
gave higher dissolution of gliclazide (Table I, GLF9, GLF4, GMF9, GMF4, GSF9, GSF4,
GMTF9, GMTF4, GSCF9, GSCF4) than the formulations containing higher drug concen-
trations (7 and 10 %, m/m) (Table I, GLF10, GLF11, GMF10, GMF11, GSF10, GSF11,
GMTF10, GMTF11, GSCF10, GSCF11). When different ordered mixture formulations were
compared for a change in the drug dissolution rate after 10 minutes with the increase of
drug concentration from 1 to 10 % (m/m), it was found that the decrease was 16.4, 13.3,
20.1, 12.3 and 29.7 % with lactose, mannitol, sorbitol, maltitol and sodium chloride con-
taining ordered mixtures respectively. At higher drug concentrations, 7 % (m/m) or more,
uneven coatings and loadings above monolayer coverage of hydrophobic drug particles
reduced the drug dissolution rates due to incomplete drug deagglomeration and carrier
solubilization. Dissolution rate of ordered mixtures with gliclazide concentration of 1, 5
and 7 % (m/m) was faster than gliclazide suspension. Drug concentration of 10 % (m/m),
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in ordered mixtures of sugar and sugar alcohols, decreased the dissolution rate, which
approached the release rate of drug suspension. In case of ordered mixtures of gliclazide
and sodium chloride, the dissolution rate of gliclazide was even lower than that of the
drug suspension (Table I).
Mathematical modeling of release kinetics. – The regression parameters obtained after
fitting various release kinetic models to the in vitro dissolution data are listed in Table
III. After fitting these models to the dissolution data of formulations, the selection was
based on comparison of higher determination coefficients. Drug release kinetics for or-
dered mixtures fitted best the Hixson-Crowell model. Ordered mixtures disintegrated
rapidly, followed by quick dissolution of water soluble excipients (lactose, mannitol, sor-
bitol, maltitol and sodium chloride), thereby forming a drug suspension consisting of
discrete primary drug particles. Wetting of hydrophobic drug particles was further ai-
ded by the presence of surfactant, which also reduced aggregation. Surface specific dis-
solution rate increased as the particle size of hydrophobic drugs decreased, especially
for micronized drugs. The dissolution rate enhancement was anticipated due to the ra-
pid decrease in thickness of the stagnant diffusion layer around micronized drug parti-
cles. Small diffusion boundary layer thickness resulted in faster transport of dissolved
molecules from the particle surface. Therefore, it was anticipated that all the ordered mix-
ture formulations followed the cube root law enunciated by Hixson-Crowell.
Comparison of dissolution data. – The dissolution rate of glicazide from pure drug pow-
der was extremely slow. Increase of 3.2 to 7.7 fold in cumulative percent drug release
from ordered mixtures after 10 minutes (Table I) was observed. On the basis of cumula-
tive percent dissolution and dissolution efficiency data (Table IV), the order of dissolu-
tion rate enhancement with various ordered mixtures was: mannitol (GMF4) > lactose
(GLF4) > maltitol (GMTF4) > sorbitol (GSF4) > NaCl (GSCF4). The relative dissolution
rate (RDr) of different formulations to gliclazide alone indicated that all sugar and sugar
alcohols were equally effective in increasing the dissolution rate up to 30 minutes.
The results of univariate ANOVA (Table IV) showed that the cumulative percent drug
dissolved was significantly different at each time point for different formulations, so
time ´ group interactions were found to be significant in all formulations (p < 0.05) com-
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Zero-order First-order Higuchi Hixson-Crowell
GLF4 0.519 0.801 0.683 0.956
GMF4 0.608 0.915 0.768 0.972
GSF4 0.404 0.588 0.57 0.968
GMTF4 0.545 0.695 0.714 0.988
GSCF4 0.77 0.987 0.901 0.986
pared to the glicazide suspension, i.e., dissolved was the dissolution profiles were not
parallel and ordered mixtures had improved the dissolution rate of gliclazide.
When the ordered mixture formulations were compared to the GMF4 formulation
(p < 0.05) by univariate ANOVA, the percent drug dissolved from GLF4 and GSF4 were
found not significantly different after the second minute while that from GMTF4 was
not significantly different after ten minutes. It was also observed that the percent drug
dissolved for GSCF4 showed lower release than the other formulations. Differences be-
tween GSCF4 and the reference GMF4 were also significant (p < 0.001) at all time points
(Fig. 2 and Table IV) which means that dissolution profiles were not parallel.
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Fig. 2. Dissolution profiles of gliclazide alone and some selected ordered mixture formulations: a)
GLF4, GSF4; b) GMF4, GSCF4, GMTF4. Mean ± SD, n = 3.
Table IV. Dissolution parameters of various ordered mixtures
Formulation
Dissolution parameter
DP2 min (%) DP10 min (%) DP60 min (%) DE5 min (%) DE15 min (%) RDr30 min (%)
GMF4 80.54b 96.02b 102.02b 85.38 96.73 2.96
GLF4 74.54a,b 96.75b 102.54b 81.67 97.49 2.96
GSF4 66a,b 94.31b 100.08b 78.8 98.57 2.98
GMTF4 70.15a,b 92.69a,b 100.75b 78.05 96.03 2.96
GSCF4 29.38a,b 66.71a,b 98.52a,b 37.74 73.6 2.64
Gliclazide
suspension
61.69 76.52 88.86 70.49 79.59 2.58
DP – Cumulative percent drug release at a particular time.
DE (%): Dissolution efficiency at a particular time. Dissolution efficiency (%) up to 5 min (DE5 min) and 15







RDr30 min – Relative dissolution rate after 30 minutes, i.e., ratio of cumulative percent drug release from formu-
lation at 30 minute to cumulative percent drug released from pure drug.
a Significant difference in cumulative percent drug release between the formulation and GMF4 formulation by
univariate ANOVA, at the same time point; p < 0.05.
b Significant difference in cumulative percent drug release between the formulation and gliclazide suspension
by univariate ANOVA, at the same time point, p < 0.05.
Higher dissolution rate of gliclazide in ordered mixtures was therefore attributed to
improved wetting of the drug owing to attachment of smaller size drug particles over
the surface of water soluble excipients, i.e., mannitol, lactose, etc. Mannitol and lactose
thus physically separated drug particles, thereby preventing aggregation after introduc-
tion of ordered mixtures to the dissolution medium. Hydrophilic carriers are known to
interact with drug molecules mainly by electrostatic forces and occasionally by other ty-
pes of forces like hydrogen bonds but this phenomenon is drug- and excipient-specific.
Mannitol and lactose thus incite a solubilizing effect. The difference in their ability of
dissolution rate enhancement might be due to the difference in the solubilizing effect in
the dissolution medium. Hydrophilic carriers attract the dissolution medium and increa-
se its amount in the immediate vicinity of the gliclazide surface. Addition of surfactant,
SLS, to the ordered mixture further aided the reduction of surface tension of the dissolu-
tion medium, thereby improving wetting and preventing aggregation of drug particles.
Superdisintegrant, SSG, was helpful in disintegrating the granules and dispersing dis-
crete drug particles in the entire dissolution medium, so that the system behaved like a
well stirred aqueous dispersion.
CONCLUSIONS
Ordered mixtures of acceptable homogeneity can be prepared by simple manual
mixing in a vial. Choice of carrier played an important role in improving gliclazide dis-
solution from prepared ordered mixtures. The order of dissolution rate enhancement of
gliclazide from different ordered mixtures was: mannitol > lactose > maltitol > sorbitol >
sodium chloride. Coarse granules of 355–710 mm were more effective than fine particles
in improving the gliclazide dissolution. Dissolution rate from ordered mixtures of glicla-
zide concentration 1, 5 and 7 % (m/m) were higher than the dissolution from gliclazide
suspension. Hixson Crowell model described the drug release from ordered mixtures
which was presumably due to surface specific drug dissolution from discrete primary
drug particles in the dissolution medium.
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S A @ E T A K
Pove}anje osloba|anja gliklazida iz smjesa dobivenih geometrijskim mije{anjem
VIKAS A. SAHARAN i PRATIM K. CHOUDHURY
Te{ko topljivi antidijabetik gliklazid izabran je za prou~avanje utjecaja pomo}nih tvari
na pove}anje osloba|anja. Homogene smjese mikroniziranog gliklazida s laktozom, ma-
nitolom, sorbitolom, maltitolom i natrijevim kloridom pripravljene su ru~nim tresenjem
staklenih bo~ica s lijekom i pomo}nom tvari/tvarima. Na osloba|anje lijeka utjecali su
vrsta vodotopljivog ekscipijensa, dodatak surfaktanta i superdezintegratora, udio lijeka
i veli~ina ~estica punila. Sve vodotopljive pomo}ne tvari pove}avale su osloba|anje lje-
kovite tvari i to sljede}im redom: manitol > laktoza > maltitol > sorbitol > natrijev klo-
rid. Najbolje osloba|anje lijeka bilo je iz kompozitnih granula veli~ine 355 do 710 mm. Iz
smjesa s manjom veli~inom ~estica punila i ve}im udjelom lijeka osloba|anje lijeka bilo
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je manje. Kineti~ko modeliranje osloba|anja najbolje je odgovaralo Hixson-Crowellovom
modelu, {to ukazuje na to da sve formulacije prili~no dobro slijede zakon tre}eg korijena.
Klju~ne rije~i: gliklazid, ekscipijens, osloba|anje, topljivost, smjese dobivene geometrijskim mije{anjem
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